(READ)Â FDA fast-tracked RSV shot linked to infant deaths
The following is from Children’s Health Defense. Nirsevimab, marketed by Sanofi and AstraZeneca as Beyfortus is a drug developed to protect infants from RSV (respiratory syncytial virus), a virus that can lead to serious respiratory infections. It was fast-tracked for approval by the US […]
(READ) FDA fast-tracked RSV shot linked to infant deaths Read More »
